Upstaza: First Gene Therapy For Ultra-Rare Disorder AADC Deficiency Receives English Funding

New genetic engineering platforms
Upstaza is a gene therapy for children with AADC deficiency • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography